Physician

Wederson Marcos Claudino, MD

According to 2025 Medicare claims, Wederson Claudino, MD (NPI: 1588977391) practices hematology/oncology in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is MERCY HEALTH PHYSICIANS KENTUCKY SPECIALTY CARE LLC (NPI: 1700408093; TIN: 850907823) and primary practice location at 42003-7915. Claudino is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), IRCCO (ACO ID: A2619), The Rural Advantage LLC (ACO ID: A5257), and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Claudino's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 678 traditional Medicare patients, billed 4,658 HCPCS/CPT codes, and received $240,448 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,513 prescription claims across 598 beneficiaries totaling $7,193,851 in drug costs, led by Revlimid (Lenalidomide). DME data shows 28 claims. Open Payments data shows 22 records totaling $138,073. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $62,190 to $7,193,851. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,424 to $10,698.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.5M2016 Medicare payment: $162,855 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,324,553 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,450,611 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,096,278 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $157,126 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $186,860 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $192,683 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $208,613 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $240,448 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201625115,593$162,855
201755889,510$1,324,553
2018669174,814$2,450,611
201974060,147$1,096,278
20206862,601$157,126
20216682,561$186,860
20226492,937$192,683
20236743,001$208,613
20246784,658$240,448

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6M$7.2M2015 Drug cost: $62,190 (USD; Tot_Drug_Cst)2016 Drug cost: $271,680 (USD; Tot_Drug_Cst)2017 Drug cost: $1,304,356 (USD; Tot_Drug_Cst)2018 Drug cost: $1,949,279 (USD; Tot_Drug_Cst)2019 Drug cost: $3,660,005 (USD; Tot_Drug_Cst)2020 Drug cost: $4,604,743 (USD; Tot_Drug_Cst)2021 Drug cost: $5,339,225 (USD; Tot_Drug_Cst)2022 Drug cost: $5,058,207 (USD; Tot_Drug_Cst)2023 Drug cost: $5,769,965 (USD; Tot_Drug_Cst)2024 Drug cost: $7,193,851 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201549103$62,190
2016115299$271,680
20172371,242$1,304,356
20183221,947$1,949,279
20193842,397$3,660,005
20204322,787$4,604,743
20215043,321$5,339,225
20225243,633$5,058,207
20235754,261$5,769,965
20245984,513$7,193,851

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$27K$54K2017 Medicare payment: $16,620 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $53,711 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,830 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $10,986 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $7,488 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $5,002 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $18,582 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $630 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R86$16,620
201837229$53,711
201911131$13,830
2020N/R143$10,986
202134149$7,488
202223149$5,002
202339126$18,582
2024N/R28$630

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more154291$104
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more312995$68
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes218787$58
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more240356$46
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4251,419$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide481,302$906,097
CabometyxCabozantinib S-Malate411,188$807,733
LenalidomideLenalidomide721,827$790,068
BrukinsaZanubrutinib401,200$579,348
IbrancePalbociclib391,092$565,426

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8700Temozolomide, oral, 5 mgNN/R11$404
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R17$226

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$1,073E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.9$137,000Merck Sharp & Dohme LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wederson Marcos Claudino, MD?

Tedicare shows public-source Medicare data for Wederson Marcos Claudino, MD (NPI 1588977391), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wederson Marcos Claudino, MD have ACO affiliation data?

Wederson Marcos Claudino, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215), IRCCO (MSSP, ACO ID A2619), The Rural Advantage LLC (MSSP, ACO ID A5257), and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Wederson Marcos Claudino, MD?

Wederson Marcos Claudino, MD is linked to MERCY HEALTH PHYSICIANS KENTUCKY SPECIALTY CARE LLC (billing NPI 1700408093) in the available physician profile data.

Does Wederson Marcos Claudino, MD have Open Payments data?

Wederson Marcos Claudino, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.